Description
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
OncQuer TM HRD testing
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
TAT:
Specimen Type:
Genomics Single Test
Other Tests
-
249%
Endopredict
Identification of therapeutically relevant gene mutations for Myeloid cancerCancer
-
263%
MPL Mutation Detection
Exon 10
-
264%
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
OncQuer TM Scout LB EGFR Response Test
Identification gene mutations leading to sensitivity and resistance to EGFR therapy
-
222%
BRCA1 BRCA2 TP53 Gene Testing (Blood) By NGS
Panel of BRCA1&2 Genes
Reviews
There are no reviews yet.